Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report.
about
Regulation of glycogen synthase kinase-3 during bipolar mania treatmentStress-Related Immune Markers in Depression: Implications for TreatmentOmics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric DisordersEpigenetic epidemiology: promises for public health researchPeripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric researchMicroRNAs as biomarkers for CNS diseaseBiomarkers in schizophrenia: A focus on blood based diagnostics and theranosticsBlood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorderFunctional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndromeDeficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.Gene expression alterations in bipolar disorder postmortem brains.Association analyses of the interaction between the ADSS and ATM genes with schizophrenia in a Chinese population.The blood of the insane.Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative?Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation.Parallel changes in gene expression in peripheral blood mononuclear cells and the brain after maternal separation in the mouse.Gene expression profiling of xeroderma pigmentosum.Validation of endogenous controls for gene expression studies in peripheral lymphocytes from war veterans with and without PTSD.Is human blood a good surrogate for brain tissue in transcriptional studies?Gene expression profiling in whole blood identifies distinct biological pathways associated with obesity.Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value DecompositionMicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia.Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophreniaEvidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophreniaMarked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients.Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples.A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genesBlood-based gene-expression biomarkers of post-traumatic stress disorder among deployed marines: A pilot studyCustomizing microarrays for neuroscience drug discovery.Temporal lobe and "default" hemodynamic brain modes discriminate between schizophrenia and bipolar disorderUtilization of never-medicated bipolar disorder patients towards development and validation of a peripheral biomarker profile.Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study.Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model.Systematic review of genome-wide gene expression studies of bipolar disorderAnalysis of whole genome biomarker expression in blood and brainPsychiatry as a clinical neuroscience discipline.Impact of DISC1 variation on neuroanatomical and neurocognitive phenotypesSimilarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relativesHigh dimensional endophenotype ranking in the search for major depression risk genes.Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.
P2860
Q24594534-7CAD3607-71AA-40F0-90EE-C4C1F758129EQ26771607-63DB44A0-63DC-4967-BF5E-A48C962BD5B7Q26784904-1B462E3E-0527-4DAB-BF75-ABCB3DABB986Q26864455-D3CAEBD1-63CD-485A-9043-43BC9F09CE17Q27012892-6B079AF9-C612-4E7A-AEED-E5BAD2759D8FQ27013998-56D4FDF8-2306-4986-9A44-8DD583F5B97FQ28068871-AAB8FFC8-7814-4464-9509-E2B3400F829BQ28480601-9EC3E1AF-D3DD-4776-A7EB-DFC6FB83967AQ28730977-633D56D0-F6A1-40D4-8954-270A5F985090Q30495108-5024ED3F-C2FE-4259-9450-DCADB881B01EQ30536705-DC5DDCFA-1DD1-45A1-BAEC-46E461D96A16Q30856619-540BD4FA-C6E4-4AE0-8359-8D33AA2C028CQ33276472-C608DBC4-BC35-45E6-BB25-2F176EEFF443Q33342771-B01BAA8E-A22D-4813-9FBE-79595FC5F5DCQ33505860-82ACE447-0EE7-4C9E-B970-1D75526F636BQ33506763-1B82833E-9299-492D-93FC-571F0A4E636EQ33540030-A9FC95D4-3A45-40B4-B508-AF4688FC9008Q33551453-50B36E24-0322-4465-9ED8-8EDE9A1B2224Q33723516-9D50ECE9-331A-4CE7-86F2-3404D0655292Q33759896-59A29232-750D-47D4-9A20-A9FDBE6991B4Q33901487-73F0E1A6-7B3F-48AD-8C72-A132F8C3904DQ33955198-D51DADB5-6394-4D89-B838-2B5A8A254AF1Q34098621-B30E445D-C030-4390-818C-C74CEE3A048CQ34113374-C6B36F07-4F30-462B-859D-2A3DD3708F1EQ34185951-BA06ED88-7E75-4D17-9EF4-99091684645AQ34194779-99C19ECC-9961-45DE-BB11-22AD73D51252Q34326175-19D3698F-FE8D-4295-BEF0-4DDEA228C8D1Q34348538-C1DB1F6A-C45E-4BDF-9E6F-5AA09DA9B24AQ34619255-C0E24394-83CD-4336-8B37-79CB72AC376BQ34692922-0D674F51-3BD7-4A24-8450-1F860970B32DQ34798059-B0953D70-6E3E-40D4-9FD0-F33777DFDF78Q34877401-48549E4B-D35D-4C4F-9E59-D5F91C47AF15Q34896648-FD7F867D-E0C9-4A45-809C-957EDD54A56CQ34941081-6316E5A9-EB71-49B6-B86F-5D91D6B229EBQ34994239-57BE1132-B901-465D-B5E6-7E52D6C01B2CQ35062086-07A9B95B-A8E3-4DA6-8603-A3A6AC1A4CE0Q35103491-07F26902-58E5-4BEA-B6E0-382F4FCE51F8Q35542783-9BDBB5D0-EE37-4825-A647-11C9D1F2C85FQ35592683-8E285990-6525-4E9C-A640-55DE9CFBF347Q35603078-A735AFE1-656E-412D-B1DB-6484C4C2E9D6
P2860
Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Assessing the validity of bloo ...... isorder: a preliminary report.
@en
Assessing the validity of bloo ...... isorder: a preliminary report.
@nl
type
label
Assessing the validity of bloo ...... isorder: a preliminary report.
@en
Assessing the validity of bloo ...... isorder: a preliminary report.
@nl
prefLabel
Assessing the validity of bloo ...... isorder: a preliminary report.
@en
Assessing the validity of bloo ...... isorder: a preliminary report.
@nl
P2093
P356
P1476
Assessing the validity of bloo ...... isorder: a preliminary report.
@en
P2093
Kou Ge Shyu
Min-Min Tsuang
Ming T Tsuang
Nadine Nossova
Shi-Chin Guo
P356
10.1002/AJMG.B.30161
P577
2005-02-01T00:00:00Z